The Genetic Obesity ID
(GO-ID) Genotyping Study

looks at samples of people’s genes to determine if they may have rare genetic disorders of obesity—specifically, POMC (pro‑opiomelanocortin) deficiency or LEPR (leptin receptor) deficiency.

There are currently no treatments for POMC or LEPR deficiencies. While these are rare genetic disorders, researchers suspect that many people have not yet been diagnosed.

Learn more about the GO-ID Genotyping Study:

I am a Healthcare Provider
I am a Patient or Caregiver
The GO-ID Genotyping Study is supported by a grant from Rhythm Pharmaceuticals, Inc. The content on this site is intended for use by patients, caregivers, and healthcare professionals for informational purposes only and is not intended to be taken as medical advice.
Back to Top
 

By clicking the following link, you are leaving this website to take a survey on another website that is not controlled by Rhythm.

Continue to the survey